- Home
- PRTS vs SPRO Comparison
PRTS vs SPRO Comparison
Compare PRTS & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTS
- SPRO
- Stock Information
- Founded
- PRTS 1995
- SPRO 2013
- Country
- PRTS United States
- SPRO United States
- Employees
- PRTS N/A
- SPRO N/A
- Industry
- PRTS Auto & Home Supply Stores
- SPRO Biotechnology: Pharmaceutical Preparations
- Sector
- PRTS Consumer Discretionary
- SPRO Health Care
- Exchange
- PRTS Nasdaq
- SPRO Nasdaq
- Market Cap
- PRTS 52.5M
- SPRO 63.0M
- IPO Year
- PRTS 2007
- SPRO 2017
- Fundamental
- Price
- PRTS $0.91
- SPRO $1.00
- Analyst Decision
- PRTS Buy
- SPRO Buy
- Analyst Count
- PRTS 3
- SPRO 3
- Target Price
- PRTS $1.60
- SPRO $5.00
- AVG Volume (30 Days)
- PRTS 381.7K
- SPRO 213.3K
- Earning Date
- PRTS 10-29-2024
- SPRO 11-14-2024
- Dividend Yield
- PRTS N/A
- SPRO N/A
- EPS Growth
- PRTS N/A
- SPRO N/A
- EPS
- PRTS N/A
- SPRO 0.06
- Revenue
- PRTS $611,705,000.00
- SPRO $106,455,000.00
- Revenue This Year
- PRTS N/A
- SPRO N/A
- Revenue Next Year
- PRTS $1.58
- SPRO N/A
- P/E Ratio
- PRTS N/A
- SPRO $15.99
- Revenue Growth
- PRTS N/A
- SPRO 37.01
- 52 Week Low
- PRTS $0.68
- SPRO $1.00
- 52 Week High
- PRTS $3.44
- SPRO $1.89
- Technical
- Relative Strength Index (RSI)
- PRTS 42.90
- SPRO 31.12
- Support Level
- PRTS $0.91
- SPRO $1.12
- Resistance Level
- PRTS $1.01
- SPRO $1.20
- Average True Range (ATR)
- PRTS 0.05
- SPRO 0.04
- MACD
- PRTS -0.02
- SPRO -0.01
- Stochastic Oscillator
- PRTS 12.11
- SPRO 13.67
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
About SPRO Spero Therapeutics Inc.
Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate, being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.